DURO, GIOVANNI
 Distribuzione geografica
Continente #
AS - Asia 2.881
NA - Nord America 2.175
EU - Europa 987
SA - Sud America 531
Continente sconosciuto - Info sul continente non disponibili 157
AF - Africa 51
OC - Oceania 10
Totale 6.792
Nazione #
US - Stati Uniti d'America 2.054
SG - Singapore 1.149
CN - Cina 678
IT - Italia 406
BR - Brasile 393
VN - Vietnam 306
HK - Hong Kong 254
FR - Francia 160
NL - Olanda 133
BD - Bangladesh 117
KR - Corea 106
GB - Regno Unito 75
JP - Giappone 64
CA - Canada 58
DE - Germania 56
IN - India 47
AR - Argentina 40
FI - Finlandia 37
ID - Indonesia 28
CO - Colombia 25
EC - Ecuador 24
MX - Messico 22
PL - Polonia 18
IQ - Iraq 17
TR - Turchia 17
ES - Italia 16
CL - Cile 13
IL - Israele 13
ZA - Sudafrica 13
JM - Giamaica 11
SA - Arabia Saudita 11
VE - Venezuela 11
AU - Australia 10
EG - Egitto 10
RU - Federazione Russa 10
PH - Filippine 9
SE - Svezia 9
UA - Ucraina 9
PK - Pakistan 8
GT - Guatemala 7
LT - Lituania 7
PE - Perù 7
PY - Paraguay 7
UZ - Uzbekistan 7
AE - Emirati Arabi Uniti 6
BO - Bolivia 6
DZ - Algeria 6
MA - Marocco 6
AT - Austria 5
TT - Trinidad e Tobago 5
AZ - Azerbaigian 4
BE - Belgio 4
CZ - Repubblica Ceca 4
GR - Grecia 4
JO - Giordania 4
KZ - Kazakistan 4
LB - Libano 4
MY - Malesia 4
TH - Thailandia 4
TN - Tunisia 4
UY - Uruguay 4
BG - Bulgaria 3
CR - Costa Rica 3
EE - Estonia 3
HN - Honduras 3
IE - Irlanda 3
NI - Nicaragua 3
NP - Nepal 3
PT - Portogallo 3
SC - Seychelles 3
SK - Slovacchia (Repubblica Slovacca) 3
AL - Albania 2
AM - Armenia 2
BA - Bosnia-Erzegovina 2
BY - Bielorussia 2
CH - Svizzera 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
HR - Croazia 2
HU - Ungheria 2
KE - Kenya 2
LV - Lettonia 2
SN - Senegal 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
TW - Taiwan 2
AG - Antigua e Barbuda 1
AO - Angola 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BS - Bahamas 1
CI - Costa d'Avorio 1
CU - Cuba 1
GD - Grenada 1
GE - Georgia 1
GY - Guiana 1
KG - Kirghizistan 1
KH - Cambogia 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
Totale 6.624
Città #
Singapore 690
Santa Clara 489
San Jose 279
Hefei 247
Hong Kong 246
Ashburn 170
Lauterbourg 128
Beijing 118
Ho Chi Minh City 102
Seoul 101
Los Angeles 85
Hanoi 75
Tokyo 49
Dallas 48
Rome 36
New York 31
Milan 28
Buffalo 27
São Paulo 27
Naples 26
Guangzhou 25
Frankfurt am Main 24
Council Bluffs 22
Orem 21
Helsinki 19
Lappeenranta 17
Houston 16
London 16
Palermo 16
Atlanta 15
Da Nang 15
Brasília 13
Brooklyn 13
Florence 13
Rio de Janeiro 13
Curitiba 12
Haiphong 12
Minamishinagawa 12
Montreal 12
Phoenix 12
Chicago 11
Düsseldorf 11
Ninh Bình 11
Warsaw 11
Charlotte 10
Toronto 10
Bengaluru 9
Campinas 9
Chennai 9
Elk Grove Village 9
Hyderabad 9
Boardman 8
Cairo 8
Las Vegas 8
Mexico City 8
Padua 8
Stockholm 8
Amsterdam 7
Bari 7
Guayaquil 7
Miami 7
Philadelphia 7
Quito 7
The Bronx 7
Ankara 6
Baghdad 6
Guatemala City 6
Munich 6
Salvador 6
Tashkent 6
Austin 5
Bandung 5
Belo Horizonte 5
Biên Hòa 5
Blumenau 5
Buenos Aires 5
Catania 5
Genoa 5
Jeddah 5
Johannesburg 5
Kingston 5
Memphis 5
Newark 5
Porto Alegre 5
Portsmouth 5
Redondo Beach 5
Ribeirão Preto 5
Santiago 5
Thái Bình 5
Turin 5
Vũng Tàu 5
Aparecida de Goiânia 4
Baku 4
Bogotá 4
Boston 4
Bắc Ninh 4
Caracas 4
Cincinnati 4
Columbus 4
Detroit 4
Totale 3.703
Nome #
Sex Differences in Anderson-Fabry Cardiomyopathy: Clinical, Genetic, and Imaging Analysis in Women 132
Increased glucosylsphingosine levels and Gaucher disease in GBA1-associated Parkinson's disease 116
Expanded screening for Fabry disease in patients with chronic kidney disease not on dialysis: a multicenter Italian experience 111
miR-126-3p and miR-21-5p as Hallmarks of Bio-Positive Ageing; Correlation Analysis and Machine Learning Prediction in Young to Ultra-Centenarian Sicilian Population 108
Diagnosis of Fabry Disease Using Alpha-Galactosidase A Activity or LysoGb3 in Blood Fails to Identify Up to Two Thirds of Female Patients 106
Highlights of Precision Medicine, Genetics, Epigenetics and Artificial Intelligence in Pompe Disease 103
Molecular and clinical studies in five index cases with novel mutations in the GLA gene. 89
Mutations in the GLA Gene and LysoGb3: Is It Really Anderson-Fabry Disease? 84
Can Be miR-126-3p a Biomarker of Premature Aging? An Ex Vivo and In Vitro Study in Fabry Disease 84
A classical phenotype of Anderson-Fabry disease in a female patient with intronic mutations of the GLA gene: a case report 84
The Identification of a Novel Pathogenic Variant of the GLA Gene Associated with a Classic Phenotype of Anderson–Fabry Disease: A Clinical and Molecular Study 82
Early Cardiac involvement affects left ventricular longitudinal function in females carrying ?- galactosidase a mutation role of hybrid positron emission tomography and magnetic resonance imaging and speckle-tracking echocardiography 78
Identification of Four New Mutations in the GLA Gene Associated with Anderson–Fabry Disease 78
Hemochromatosis Mimicked Gaucher Disease: Role of Hyperferritinemia in Evaluation of a Clinical Case 77
Gaucher disease prevalence in 600 patients affected by monoclonal gammopathy of undetermined significance 77
Pompe disease: pathogenesis, molecular genetics and diagnosis 77
Transforming Growth Factor 1 T29c Gene Polymorphism And Hypertension: Relationship With Cardiovascular And Renal Damage 75
Gaucher Disease or Acid Sphingomyelinase Deficiency? The Importance of Differential Diagnosis 75
Fabry Disease and Inflammation: Potential Role of p65 iso5, an Isoform of the NF-κB Complex 75
Identification of Novel Mutations in Patients Affected by Gaucher Disease 74
Polymorphisms in the intergenic region of the sea urchin Paracentrotus lividus ribosomal DNA 72
A novel and recurrent mutation in the SERPING1 gene in patients with hereditary angioedema 72
Late-Onset Pompe Disease with Normal Creatine Kinase Levels: The Importance of Rheumatological Suspicion 72
Systematic DNA Study for Fabry Disease in the End Stage Renal Disease Patients from a Southern Italy Area 70
Mutation Spectrum of GAA Gene in Pompe Disease: Current Knowledge and Results of an Italian Study 70
Translation of Basic Research into Clinics: Killer Immunoglobulin-like Receptors Genes in Autoimmune and Infectious Diseases 67
Calnexin is down-regulated in Fabry disease. A possible implication in protein misfolding 67
Newborn screening for fabry disease in northeastern italy: Results of five years of experience 65
Myocardial dysfunction in Anderson-Fabry disease (AFD) without ventricular hypertrophy 65
De novo mutation in a male patient with Fabry disease: a case report 64
Simple and inexpensive dot-blot apparatus 62
HLA-C1 ligands are associated with increased susceptibility to systemic lupus erythematosus 61
European Biotech week 61
A new p65 isoform that bind the glucocorticoid hormone and is expressed in inflammation liver diseases and COVID-19 60
Up-regulation of gamma-enolase in PMC from Fabry patients 59
Fabry disease, a complex pathology not easy to diagnose 59
A pilot study of circulating microRNAs as potential biomarkers of Fabry disease 58
Prevalence of GLA gene mutations and polymorphisms in patients with multiple sclerosis: A cross-sectional study 58
Misdiagnosi di Febbre Mediterranea Familiare in pazienti con Malattia di Anderson-Fabry 57
Blood group does not appear to affect longevity a pilot study in centenarians from Western Sicily. 56
Alteration of proteomic profiles in PBMC isolated from patients with Fabry disease: preliminary findings. 55
Fabry Disease Beyond Storage: The Role of Inflammation in Disease Progression 54
Case report: De novo mutation of a-galactosidase A in a female patient with end-stage renal disease: report of a case of late diagnosis of Anderson–Fabry disease 53
Age-related inflammation: the contribution of different organs, tissues and systems. how to face it for therapeutic approaches. 52
Alteration of proteomic profiles in PBMC isolated from patients with Fabry disease: preliminary findings 52
Fabry disease and multiple sclerosis misdiagnosis: the role of family history and neurological signs. 50
Circulating miRNAs in Successful and Unsuccessful Aging. A Mini-review 50
The historical relevance of urine and the future implications 49
High variability of fabry disease manifestations in an extended italian family 48
GM Allotypes and COVID-19. A Pilot Study Performed on Sicilian Patients. 48
Multiplex Ligation Probe Amplification and Sanger Sequencing: Light and Shade in the Diagnosis of Lysosomal Storage Disorders 46
Analysis of mutations in the GLA and MEFV genes might determines a genetic variant of Fabry diseases 46
Distribution of KIR Genes and Their HLA Ligands in Different Viral Infectious Diseases: Frequency Study in Sicilian Population 45
Fabry disease: a proteomic approach 45
Identification of a novel mutation in the alpha-galactosidase A gene in patients with Fabry disease 44
Plasma and dried blood spot lysosphingolipids for the diagnosis of different sphingolipidoses: A comparative study 44
Identification of cross-reactive and genuine Parietaria judaica pollen allergens 44
DNA methylation impact on Fabry disease 44
How Important Are Genes to Achieve Longevity? 44
VEXAS Syndrome: Genetics, Gender Differences, Clinical Insights, Diagnostic Pitfalls, and Emerging Therapies 43
Proteomic approach in Fabry disease: a case report 43
Immunopathology and Immunosenescence, the Immunological Key Words of Severe COVID-19. Is There a Role for Stem Cell Transplantation? 43
Healthy ageing and Mediterranean diet: A focus on hormetic phytochemicals 43
Novel alpha-galactosidase A mutation in a female with recurrent strokes. 43
Novel alpha-galactosidase A mutation in patients with severe cardiac manifestations of Fabry disease 42
Assignment of disulphide bridges in Parj 2.0101, a major allergen of Parietaria judaica pollen 42
Misdiagnosis of familial Mediterranean fever in patients with Anderson-Fabry disease 42
KIR2DL3 and the KIR ligand groups HLA-A-Bw4 and HLA-C2 predict the outcome of hepatitis B virus infection 42
Mucopolysaccharidosis Type I and α-Mannosidosis—Phenotypically Comparable but Genetically Different: Diagnostic and Therapeutic Considerations 42
Immune-inflammatory responses and oxidative stress in Alzheimer' disease: therapeutic implications 41
Inter-familial and intra-familial phenotypic variability in three Sicilian families with Anderson-Fabry disease 41
Genetic screening of Fabry patients with EcoTILLING and HRM technology 41
Parietaria judaica ns-LTP antigen variants, uses thereof and compositions comprising them 41
Alterazioni introniche in soggetti con sintomatologia riconducibile alla malattia di Fabry 41
HLA and Killer Cell Immunoglobulin-like Receptors Influence the Natural Course of CMV Infection. 40
A family with various symptomatology suggestive of Anderson-Fabry disease and a genetic polymorphism of alpha galactosidase A gene 40
null 40
An update on allergens. Parietaria pollen allergens. 38
Severe hypertrophic cardiomyopathy in a patient with atypical Anderson-Fabry disease. 38
Detection of RAS mutations in circulating tumor DNA: a new weapon in an old war against colorectal cancer. A systematic review of literature and meta-analysis 37
Voltage gradient electrophoresis of nucleic acids on agarose gels 36
Hypoallergenic fragment of Par j 2 increases functional expression of Toll-like receptors in atopic children 35
Ambiente e Salute: dal monitoraggio aerobiologico alla prevenzione 35
Intragenomic recombination between homologous regions of genes II and IV promotes formation of bacteriophage f1 miniphages 35
Use of a pure allergen component 35
Readthrough transcription occurs at the rho dependent signal F1 TIV in suppressor cells 34
Response to Simsek et al. 34
IDENTIFICATION OF AN IMMUNODOMINANT IGE EPITOPE OF THE PARIETARIA JUDAICA MAJOR ALLERGEN. 34
A method for eluting DNA in a wide range of molecular weights from agarose gels 34
Germline mosaicism for the c.2021G>A (p.Arg674Gln) mutation in siblings with trismus pseudocamptodactyly. 33
Parietaria pollen allergens: a model to study the Type I allergy 33
cDNA cloning, sequence analysis and allergological characterization of Par j 2.0101, a new major allergen of the Parietaria judaica pollen 33
Varianti di allergeni NS-LTPS, loro usi e composti che le comprendono 33
Role of Immunogenetics in the Outcome of HCMV Infection: Implications for Ageing 32
Genotypic and phenotypic aspects of longevity: Results from a sicilian survey and implication for the prevention and treatment of age-related diseases 32
The immunoglobulin ? marker 17 allotype and KIR/HLA genes prevent the development of chronic hepatitis B in humans 32
Peptidi derivati dall'allergene par j 2 del polline di parietaria judaica 31
The signature of longevity in Sicily 31
Isolation of proteins and nucleic acids by electrophoresis on disposable gel columns 31
Identification of a novel and recurrent mutation in the SERPING1 gene in patients with hereditary angioedema. 31
Totale 5.500
Categoria #
all - tutte 23.702
article - articoli 20.807
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 117
Totale 44.626


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202436 0 0 0 0 0 0 0 0 4 0 26 6
2024/20252.237 79 11 160 74 467 71 12 128 114 147 524 450
2025/20263.658 173 288 332 542 658 132 480 172 206 283 270 122
2026/2027861 218 172 471 0 0 0 0 0 0 0 0 0
Totale 6.792